SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001645113-21-000009
Filing Date
2021-02-01
Accepted
2021-02-01 16:19:40
Documents
15
Period of Report
2021-01-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20210129.htm   iXBRL 8-K 34389
2 EX-99.1 noticeofsettlementmethod20.htm EX-99.1 6352
  Complete submission text file 0001645113-21-000009.txt   186798

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20210129.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvcr-20210129_cal.xml EX-101.CAL 803
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvcr-20210129_def.xml EX-101.DEF 1767
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20210129_lab.xml EX-101.LAB 24191
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20210129_pre.xml EX-101.PRE 12715
8 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20210129_htm.xml XML 11085
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 21576931
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences